Article
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm.
Cancer research - 1 Aug 2025
Oliveira Erica A, Milite Salvatore, Fernandez-Mateos Javier, Cresswell George D, Yara-Romero Erika, Vlachogiannis Georgios, Chen Bingjie, James Chela T, Patruno Lucrezia, Ascolani Gianluca, Acar Ahmet, Heide Timon, Spiteri Inmaculada, Graudenzi Alex, Caravagna Giulio, Bertotti Andrea, Graham Trevor A, Magnani Luca, Valeri Nicola, Sottoriva Andrea
Abstract excerpt
Cancer drug resistance is multifactorial, driven by heritable (epi)genetic changes but also by phenotypic plasticity. In this study, we dissected the drivers of resistance by perturbing organoids derived from patients with colorectal cancer longitudinally with drugs in sequence. Combined longitudinal lineage tracking, single-cell multiomics analysis, evolutionary modeling, and machine learning revealed that...
Topics
Join the communities discussing this publication.
